{"slug":"pt-141-trigeminal","verification":{"valid":true,"entries":2,"head":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"},"energy":{"passes":2,"tokens_in":12579,"tokens_out":2447,"tokens_total":15026,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"},"provenance":[{"ts":"2026-06-30T01:05:58.499Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Trigeminal\nSlug: pt-141-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from pep","response":"{\n  \"slug\": \"pt-141-trigeminal\",\n  \"title\": \"PT-141 for Trigeminal: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\\n\\n## Why PT-141 might help you\\n\\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\\n\\n## What the evidence actually shows\\n\\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tier: none found). All identified human data address hypoactive sexual desire disorder via central melanocortin activation. Animal and mechanistic data focus on sexual response pathways.\\n\\n## What scientists say\\n\\nResearchers describe PT-141 as a melanocortin agonist that stimulates central pathways for arousal independent of vascular effects. No published statements address trigeminal applications.\\n\\n## What people say on Reddit\\n\\nNo specific anecdotes tying PT-141 to trigeminal symptoms appear in available discussions. General peptide conversations center on sexual effects.\\n\\n## What peopl","tokens_in":12579,"tokens_out":2447,"cost":0,"prev":"genesis","hash":"468ffd273b556778fdea9177446c9d90b17fa626d7c26fe15d218fb67acd5f9e"},{"ts":"2026-07-17T02:41:12.325Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-trigeminal","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"468ffd273b556778fdea9177446c9d90b17fa626d7c26fe15d218fb67acd5f9e","hash":"ee573043888b7a36fe7bc71b1fed3ffe60456a0474582915178f6017a745a241"}]}